Menu
CoinPost
CPT Developers
Topics
Market
Events
Back
Vertex Pharmaceuticals revenue rises 12% to $3.33 billion in Q2
Sep 28, 2026 15:05 (25d ago)
Verifying
AI Summary
Vertex Pharmaceuticals increased Q2 revenue to $3.33 billion
Revenue grew 12%, driven by cystic fibrosis treatments
UBS raised Vertex’s price target from $585 to $615
Related Topics
Media
1
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.